BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Venepalli NK, Emmadi R, Danciu OC, Chowdhery R, Cabay RJ, Gaitonde S, Aardsma N, Kothari R, Liu LC, Fischer JH, Zaidi A, Russell MJ, Dudek AZ. Phase I Study of IGF-Methotrexate Conjugate in the Treatment of Advanced Tumors Expressing IGF-1R. American Journal of Clinical Oncology 2019;42:862-9. [DOI: 10.1097/coc.0000000000000611] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang P, Mak VC, Cheung LW. Drugging IGF-1R in cancer: New insights and emerging opportunities. Genes & Diseases 2022. [DOI: 10.1016/j.gendis.2022.03.002] [Reference Citation Analysis]
2 Ameline B, Kovac M, Nathrath M, Barenboim M, Witt O, Krieg AH, Baumhoer D. Overactivation of the IGF signalling pathway in osteosarcoma: a potential therapeutic target? J Pathol Clin Res 2021;7:165-72. [PMID: 33295144 DOI: 10.1002/cjp2.191] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]